The old THC/CBD ratio of marijuana medication has been challenged. The Panakeia strain, which is also known as CBG, has a high level of Cannabigerol.
Panekeia is the first cannabis plant to be free of THC. Panakeia is legally permitted to grow and market cannabis.
Let’s take a closer look at this new strain.
The Panakeia CBD Hemp Strain – Origins and Properties
Panakeia was originally developed by Hemp Trading, a Spanish cannabis company, and the Polytechnic University of Valencia. It is slowly replacing the Indica and Sativa strains in hemp-based products that are available to US patients.
Panaekia, scientifically known as ” HURV19PAN”, is a variety of hemp that has no psychoactive effects. Panakeia is a hemp variety that has a high concentration of cannabigerol, (CBG) and no Delta-8 or Delta-9THC. This can make it a very valuable commercial product.
Let’s look at the science behind CBG and how it makes Panakeia so important in the cannabis product market.
CBG is the decarboxylated cannabigerol (CBGA) form of cannabigerol, the parent molecule that other cannabinoids can be synthesized. It works in the same way as CBD and has therapeutic benefits, but does not contain high THC.
Both are endocannabinoids and could be used to treat certain illnesses. These are:
- Depression and Anxiety
- Cachexia (Wasting Syndrome)
- Chronic Pain
- Inflammatory Bowel Diseases
- Different forms of Cancer
Panakeia and CBG: Their Impact on the Future of Cannabis
CBG was only found in the cannabis plant’s residual levels before Panakeia’s development. CBG, as with most strains of cannabis, is difficult to extract from mature plants.
It is only found in a small amount (1%), as opposed to 25-30% of THC or CBD. This made it a difficult and expensive cannabinoid. Panakeia changed all that.
Panakeia has a staggering 18% CBG chemical structure. It is a low-THC strain and easy to grow, making it a viable solution to many of the current issues in the US marijuana market.
THC does not mean that a plant with a compound of 0.3% or more will fail a field compliance test. It allows for easy transportation and no legal infringement. It also means that the flower can be processed into ready-to-sell products without any THC remediation. The process is simplified in every way.
A Milestone Moment in the US Marijuana Industry
Bazalet’s increased Panekeia production is a sign of a few things:
The US market will soon be flooded with new CBD products from the cannabis plant, offering a better value proposition.
CBG compounds are capable of creating a variety of products, including cosmetics and foods.
The good news for all is the continued legalization in the US and other countries around the world. Panakeia is one example of a new breed that has been allowed to be developed by cultivators. These innovations prove that cannabis is more than CBD and THC. We should also be aware of the changes taking place in the marijuana industry.
Panakeia is the cannabis strain with the greatest chance of eliminating the legal hurdles in the medical marijuana market and best strains for anxiety and focus. It can also be as effective as other options on the market due to its CBG-focused formulation.
Panakeia brought us together in a CBG based union after a year of steady growth for the US marijuana market. It also gives us the chance to end the CBD/THC divide that has dominated the marijuana market for so many years.